Literature DB >> 25323961

The natural history of dementia.

Ee Heok Kua1, Emily Ho, Hong Hee Tan, Chris Tsoi, Christabel Thng, Rathi Mahendran.   

Abstract

This review summarizes studies on the natural history of dementia with a focus on Alzheimer's disease and vascular dementia. Understanding the course of dementia is important not only for patients, caregivers, and health professionals, but also for health policy-makers, who have to plan for national resources needed in the management of an increasing number of dementia cases. From the available published data, the life expectancy of elderly people with dementia is shorter than that of non-demented elderly. Reports on survival after a diagnosis of dementia vary from 3 to 12 years. The wide variation is partly due to the diagnostic criteria used in the studies and the sites where they were conducted (i.e. hospitals, clinics, or homes). There is an apparent difference in survival between Alzheimer's disease patients with onset of illness before 75 years and those after 75 years: the younger patients have a longer life expectancy. However, there are conflicting data on survival (in years) comparing male and female patients and comparing patients of different ethnicities. For vascular dementia, published papers on life expectancy vary between 3 to 5 years. Vascular dementia appears to have a poorer prognosis than Alzheimer's disease. The stages of severity of dementia were compared in a follow-up of a sample of Alzheimer's disease patients in Singapore, and the mean duration of the mild phase (clinical dementia rating 1) was 5.6 years, the moderate phase (clinical dementia rating 2) was 3.5 years, and the severe phase (clinical dementia rating 3) was 3.2 years. At the various phases of the disease, the demand on health-care services and economic cost are different.
© 2014 The Authors. Psychogeriatrics © 2014 Japanese Psychogeriatric Society.

Entities:  

Keywords:  Alzheimer's disease; natural history; vascular dementia

Mesh:

Year:  2014        PMID: 25323961     DOI: 10.1111/psyg.12053

Source DB:  PubMed          Journal:  Psychogeriatrics        ISSN: 1346-3500            Impact factor:   2.440


  31 in total

1.  Prevalence of CMMSE defined cognitive impairment among peritoneal dialysis patients and its impact on peritonitis.

Authors:  Yat Fung Shea; Man-Fai Lam; Mi Suen Connie Lee; Ming Yee Maggie Mok; Sing-Leung Lui; Terence P S Yip; Wai Kei Lo; Leung Wing Chu; Tak-Mao Chan
Journal:  Clin Exp Nephrol       Date:  2015-05-21       Impact factor: 2.801

2.  Differential diagnosis of Alzheimer's disease using spectrochemical analysis of blood.

Authors:  Maria Paraskevaidi; Camilo L M Morais; Kássio M G Lima; Julie S Snowden; Jennifer A Saxon; Anna M T Richardson; Matthew Jones; David M A Mann; David Allsop; Pierre L Martin-Hirsch; Francis L Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-05       Impact factor: 11.205

3.  Sequential Therapy Based on Evolvement of Patterns: A New Model for Treatment of Alzheimer's Disease.

Authors:  Jin-Zhou Tian; Jing Shi; Jing-Nian Ni; Ming-Qing Wei; Xue-Kai Zhang; Ke-Ji Chen; Yong-Yan Wang
Journal:  Chin J Integr Med       Date:  2019-05-07       Impact factor: 1.978

4.  CZ-7, a new derivative of Claulansine F, ameliorates 2VO-induced vascular dementia in rats through a Nrf2-mediated antioxidant responses.

Authors:  Dan-Dan Liu; Xia Yuan; Shi-Feng Chu; Chen Chen; Qian Ren; Piao Luo; Mei-Yu Lin; Sha-Sha Wang; Tian-Bi Zhu; Qi-di Ai; Ying-da Zang; Dong-Ming Zhang; Xin He; Zhi-Hua Huang; Hong-Shuo Sun; Zhong-Ping Feng; Nai-Hong Chen
Journal:  Acta Pharmacol Sin       Date:  2018-10-31       Impact factor: 6.150

Review 5.  Widespread sex dimorphism in aging and age-related diseases.

Authors:  Nirmal K Sampathkumar; Juan I Bravo; Yilin Chen; Prakroothi S Danthi; Erin K Donahue; Rochelle W Lai; Ryan Lu; Lewis T Randall; Nika Vinson; Bérénice A Benayoun
Journal:  Hum Genet       Date:  2019-11-01       Impact factor: 4.132

6.  The association between cognitive impairment and breast and colorectal cancer screening utilization.

Authors:  Shuang Yang; Jiang Bian; Thomas J George; Karen Daily; Dongyu Zhang; Dejana Braithwaite; Yi Guo
Journal:  BMC Cancer       Date:  2021-05-12       Impact factor: 4.430

7.  Mortality After Ischemic Stroke in Patients with Alzheimer's Disease Dementia and Other Dementia Disorders.

Authors:  Eva Zupanic; Mia von Euler; Bengt Winblad; Hong Xu; Juraj Secnik; Milica Gregoric Kramberger; Dorota Religa; Bo Norrving; Sara Garcia-Ptacek
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

Review 8.  The Roles of Nitric Oxide Synthase/Nitric Oxide Pathway in the Pathology of Vascular Dementia and Related Therapeutic Approaches.

Authors:  Han-Yan Zhu; Fen-Fang Hong; Shu-Long Yang
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

9.  Kidney Function, Kidney Function Decline, and the Risk of Dementia in Older Adults: A Registry-Based Study.

Authors:  Hong Xu; Sara Garcia-Ptacek; Marco Trevisan; Marie Evans; Bengt Lindholm; Maria Eriksdotter; Juan Jesus Carrero Pharm
Journal:  Neurology       Date:  2021-05-05       Impact factor: 9.910

10.  Bilingual problem-solving training for caregivers of adults with dementia: A randomized, factorial-design protocol for the CaDeS trial.

Authors:  ShannonB Juengst; Charlene Supnet; Chung Lin Novelle Kew; Valeria Silva; Marlene Vega; Gang Han; Brendan Kelley; Matthew Lee Smith; Gladys Maestre
Journal:  Contemp Clin Trials       Date:  2021-07-15       Impact factor: 2.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.